Crossref journal-article
Springer Science and Business Media LLC
Nature Reviews Drug Discovery (297)
Bibliography

Orchard, S., Al-Lazikani, B., Bryant, S., Clark, D., Calder, E., Dix, I., Engkvist, O., Forster, M., Gaulton, A., Gilson, M., Glen, R., Grigorov, M., Hammond-Kosack, K., Harland, L., Hopkins, A., Larminie, C., Lynch, N., Mann, R. K., Murray-Rust, P., … Thornton, J. (2011). Minimum information about a bioactive entity (MIABE). Nature Reviews Drug Discovery, 10(9), 661–669.

Authors 26
  1. Sandra Orchard (first)
  2. Bissan Al-Lazikani (additional)
  3. Steve Bryant (additional)
  4. Dominic Clark (additional)
  5. Elizabeth Calder (additional)
  6. Ian Dix (additional)
  7. Ola Engkvist (additional)
  8. Mark Forster (additional)
  9. Anna Gaulton (additional)
  10. Michael Gilson (additional)
  11. Robert Glen (additional)
  12. Martin Grigorov (additional)
  13. Kim Hammond-Kosack (additional)
  14. Lee Harland (additional)
  15. Andrew Hopkins (additional)
  16. Christopher Larminie (additional)
  17. Nick Lynch (additional)
  18. Romeena K. Mann (additional)
  19. Peter Murray-Rust (additional)
  20. Elena Lo Piparo (additional)
  21. Christopher Southan (additional)
  22. Christoph Steinbeck (additional)
  23. David Wishart (additional)
  24. Henning Hermjakob (additional)
  25. John Overington (additional)
  26. Janet Thornton (additional)
References 27 Referenced 82
  1. Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug Discov. 1, 727–730 (2002). (10.1038/nrd892) / Nature Rev. Drug Discov. by AL Hopkins (2002)
  2. Hajduk, P. J., Huth, J. R., & Tse, C. Predicting protein druggability. Drug Discov. Today 10, 1675–1682 (2005). (10.1016/S1359-6446(05)03624-X) / Drug Discov. Today by PJ Hajduk (2005)
  3. Schmidtke, P. & Barril, X. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. J. Med. Chem. 53, 5858–5867 (2010). (10.1021/jm100574m) / J. Med. Chem. by P Schmidtke (2010)
  4. Halgren, T. A. Identifying and characterizing binding sites and assessing druggability. J. Chem. Inf. Model. 49, 377–389 (2009). (10.1021/ci800324m) / J. Chem. Inf. Model. by TA Halgren (2009)
  5. Zhang, Z. & Grigorov, M. G. Similarity networks of protein binding sites. Proteins 62, 470–478 (2006). (10.1002/prot.20752) / Proteins by Z Zhang (2006)
  6. Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there? Nature Rev. Drug Discov. 5, 993–996 (2006). (10.1038/nrd2199) / Nature Rev. Drug Discov. by JP Overington (2006)
  7. The UniProt Consortium. Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 39, D214–D219 (2010). (10.1093/nar/gkq1020)
  8. Berriman, M. et al. The genome of the blood fluke Schistosoma mansoni. Nature 460, 352–358 (2009). (10.1038/nature08160) / Nature by M Berriman (2009)
  9. Brazma, A. et al. Minimum information about a microarray experiment (MIAME) — toward standards for microarray data. Nature Genet. 29, 365–371 (2001). (10.1038/ng1201-365) / Nature Genet. by A Brazma (2001)
  10. Degtyarenko, K. et al. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350 (2008). (10.1093/nar/gkm791) / Nucleic Acids Res. by K Degtyarenko (2008)
  11. Sayers, E. W. et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 39, D38–D51 (2011). (10.1093/nar/gkq1172) / Nucleic Acids Res. by EW Sayers (2011)
  12. Seiler, K. P. et al. ChemBank: a small-molecule screening and cheminformatics resource database. Nucleic Acids Res. 36, D351–D359 (2008). (10.1093/nar/gkm843) / Nucleic Acids Res. by KP Seiler (2008)
  13. Pederson, F., de Brujin, J., Munn, S. & van Leeuwen, K. Assessment of additional testing needs under REACH. Effects of (Q)SAR, risk based testing and voluntary industry activity. European Commission report EUR 20863 (2003).
  14. Vizcaino, J. A., Martens, L., Hermjakob, H., Julian, R. K. & Paton, N. W. The PSI formal document process and its implementation on the PSI website. Proteomics 7, 2355–2357 (2007). (10.1002/pmic.200700064) / Proteomics by JA Vizcaino (2007)
  15. Yeung, B. K. et al. Spirotetrahydro β-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria. J. Med. Chem. 53, 5155–5164 (2010). (10.1021/jm100410f) / J. Med. Chem. by BK Yeung (2010)
  16. Kerrien, S. et al. Broadening the horizon — level 2.5 of the HUPO-PSI format for molecular interactions. BMC Biol. 5, 44 (2007). (10.1186/1741-7007-5-44) / BMC Biol. by S Kerrien (2007)
  17. Aranda, B. et al. PSICQUIC and PSISCORE: accessing and scoring molecular interactions. Nature Methods 8, 528–529 (2011). (10.1038/nmeth.1637) / Nature Methods by B Aranda (2011)
  18. Croft, D. et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 39, D691–D697 (2011). (10.1093/nar/gkq1018) / Nucleic Acids Res. by D Croft (2011)
  19. Taylor, C. F. et al. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nature Biotech. 26, 889–896 (2008). (10.1038/nbt.1411) / Nature Biotech. by CF Taylor (2008)
  20. Orchard, S. et al. The minimum information required for reporting a molecular interaction experiment (MIMIx). Nature Biotech. 25, 894–898 (2007). (10.1038/nbt1324) / Nature Biotech. by S Orchard (2007)
  21. Bourbeillon, J. et al. Minimum Information about a protein affinity reagent (MIAPAR). Nature Biotech. 28, 650–653 (2010). (10.1038/nbt0710-650) / Nature Biotech. by J Bourbeillon (2010)
  22. Schuffenhauer, A. et al. An ontology for pharmaceutical ligands and its application for in silico screening and library design. J. Chem. Inf. Comput. Sci. 42, 947–955 (2002). (10.1021/ci010385k) / J. Chem. Inf. Comput. Sci. by A Schuffenhauer (2002)
  23. Qi, D. et al. An ontology for description of drug discovery investigations. J. Integr. Bioinform. 25 Mar 2010 (doi:10.2390/biecoll-jib-2010-126).
  24. Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci. 28, 31–36 (1988). (10.1021/ci00057a005) / J. Chem. Inf. Comput. Sci. by D Weininger (1988)
  25. Stein, S. E., Heller, S. R. & Tchekhovskoi, D. An open standard for chemical structure representation: the IUPAC chemical identifier. Proceedings of the 2003 International Chemical Information Conference (Nîmes), Infonortics, 131–143 (2003).
  26. Inglese, J., Shamu, C. E. & Guy, R. K. Reporting data from high-throughput screening of small-molecule libraries. Nature Chem. Biol. 3, 438–441 (2007). (10.1038/nchembio0807-438) / Nature Chem. Biol. by J Inglese (2007)
  27. Gene Ontology Consortium. The Gene Ontology in 2010: extensions and refinements. Nucleic Acids Res. 38, D331–D335 (2010). (10.1093/nar/gkp1018)
Dates
Type When
Created 13 years, 11 months ago (Aug. 31, 2011, 5:35 a.m.)
Deposited 2 years, 3 months ago (May 19, 2023, 12:07 a.m.)
Indexed 2 weeks, 4 days ago (Aug. 6, 2025, 9:43 a.m.)
Issued 13 years, 11 months ago (Aug. 31, 2011)
Published 13 years, 11 months ago (Aug. 31, 2011)
Published Online 13 years, 11 months ago (Aug. 31, 2011)
Published Print 13 years, 11 months ago (Sept. 1, 2011)
Funders 0

None

@article{Orchard_2011, title={Minimum information about a bioactive entity (MIABE)}, volume={10}, ISSN={1474-1784}, url={http://dx.doi.org/10.1038/nrd3503}, DOI={10.1038/nrd3503}, number={9}, journal={Nature Reviews Drug Discovery}, publisher={Springer Science and Business Media LLC}, author={Orchard, Sandra and Al-Lazikani, Bissan and Bryant, Steve and Clark, Dominic and Calder, Elizabeth and Dix, Ian and Engkvist, Ola and Forster, Mark and Gaulton, Anna and Gilson, Michael and Glen, Robert and Grigorov, Martin and Hammond-Kosack, Kim and Harland, Lee and Hopkins, Andrew and Larminie, Christopher and Lynch, Nick and Mann, Romeena K. and Murray-Rust, Peter and Lo Piparo, Elena and Southan, Christopher and Steinbeck, Christoph and Wishart, David and Hermjakob, Henning and Overington, John and Thornton, Janet}, year={2011}, month=aug, pages={661–669} }